These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders. Baron BW; Mick R; Baron JM Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897]. Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H Onkologie; 1988 Feb; 11(1):25-9. PubMed ID: 3283622 [TBL] [Abstract][Full Text] [Related]
8. Splenic irradiation following chemotherapy in chronic myelogenous leukemia. Wilson JF; Johnson RE Radiology; 1971 Dec; 101(3):657-61. PubMed ID: 5288778 [No Abstract] [Full Text] [Related]
10. Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phase. Schwarzenberg L; Mathé G; Pouillart P; Weiner R; Locour J; Genin J; Schneider M; De Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C Br Med J; 1973 Mar; 1(5855):700-3. PubMed ID: 4512003 [TBL] [Abstract][Full Text] [Related]
11. The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1. Hehlmann R; Heimpel H; Kolb HJ; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser WP; Essers U; Falge C Leuk Lymphoma; 1993; 11 Suppl 1():159-68. PubMed ID: 8251890 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of chronic myeloid leukemia]. Mey U Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538 [No Abstract] [Full Text] [Related]
13. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features. Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800 [TBL] [Abstract][Full Text] [Related]
19. Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemia. Kantarjian HM; Talpaz M; Kurzrock R; Keating MJ; McCredie KB; Gutterman J; Freireich EJ Acta Haematol; 1987; 78 Suppl 1():70-4. PubMed ID: 2449026 [TBL] [Abstract][Full Text] [Related]
20. A prospective comparison of alpha-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Haematologica; 1992; 77(3):204-14. PubMed ID: 1427426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]